DARUNAVIR
Identification of Darunavir
| No description |
Google image searchProduct monograph
Active ingredient
darunavir, 800 MG
DIN: 02521350
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 25-APR-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AE — Protease inhibitors (ATC, ATC/DDD)
- J05AE10 — DARUNAVIR (ATC/DDD)
Reference brand drug: Prezista
Pharmaceutical standard: MFR
